<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00925093</url>
  </required_header>
  <id_info>
    <org_study_id>AUH-MGP-AB-CSV-2009-1</org_study_id>
    <nct_id>NCT00925093</nct_id>
  </id_info>
  <brief_title>Study of Antibiotics in Cerebrospinal Fluid Following Intravenous Injection</brief_title>
  <official_title>Antibiotics in Cerebrospinal Fluid Following Intravenous Injection</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Aarhus University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Aarhus University Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Three different antibiotics are used to prevent infection in case of neurosurgery - this
      study examines to which extent the antibiotics penetrate from the blood to the cerebrospinal
      fluid (surrounding the brain).
    </textblock>
  </brief_summary>
  <overall_status>Withdrawn</overall_status>
  <why_stopped>
    Primary investigator left institution
  </why_stopped>
  <start_date>September 2011</start_date>
  <completion_date type="Anticipated">December 2013</completion_date>
  <primary_completion_date type="Anticipated">December 2012</primary_completion_date>
  <phase>Phase 1</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Concentration of antibiotics in cerebrospinal fluid</measure>
    <time_frame>1, 2, 4, 6, 12 hours</time_frame>
    <description>Concentration in CSF past i.v. injection</description>
  </primary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">0</enrollment>
  <condition>Neurosurgery</condition>
  <arm_group>
    <arm_group_label>Vancomycin</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Vancomycin is administered intravenously and subsequently measured in cerebrospinal fluid sample</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Teicoplanin</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Teicoplanin is administered intravenously and subsequently measured in cerebrospinal fluid sample</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Linezolid</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Linezolid is administered intravenously and subsequently measured in cerebrospinal fluid sample</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Vancomycin</intervention_name>
    <description>Vancomycin is administered intravenously and subsequently measured in cerebrospinal fluid sample</description>
    <arm_group_label>Vancomycin</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Teicoplanin</intervention_name>
    <description>Teicoplanin is administered intravenously and subsequently measured in cerebrospinal fluid sample</description>
    <arm_group_label>Teicoplanin</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Linezolid</intervention_name>
    <description>Linezolid is administered intravenously and subsequently measured in cerebrospinal fluid sample</description>
    <arm_group_label>Linezolid</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Over 18 years old

          -  Already having an external CSF drain

          -  Scheduled for neurosurgery requiring antibiotic prophylaxis (most commonly placement
             of an internal drain (&quot;shunt&quot;)

        Exclusion Criteria:

          -  Infection or colonization requiring other than standard prophylactic antibiotics
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <verification_date>June 2009</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 18, 2009</study_first_submitted>
  <study_first_submitted_qc>June 18, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 19, 2009</study_first_posted>
  <last_update_submitted>January 23, 2015</last_update_submitted>
  <last_update_submitted_qc>January 23, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">January 26, 2015</last_update_posted>
  <responsible_party>
    <name_title>Morten Gustav Poulsen, MD</name_title>
    <organization>Aarhus University Hospital, Aarhus Hospital</organization>
  </responsible_party>
  <keyword>vancomycin</keyword>
  <keyword>teicoplanin</keyword>
  <keyword>linezolid</keyword>
  <keyword>intravenous</keyword>
  <keyword>cerebrospinal fluid</keyword>
  <keyword>CSF</keyword>
  <keyword>pharmacokinetics</keyword>
  <keyword>penetration</keyword>
  <keyword>blood-brain barrier</keyword>
  <keyword>Pharmacokinetics of three antibiotics in relation to cerebrospinal fluid</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Anti-Bacterial Agents</mesh_term>
    <mesh_term>Vancomycin</mesh_term>
    <mesh_term>Linezolid</mesh_term>
    <mesh_term>Teicoplanin</mesh_term>
    <mesh_term>Antibiotics, Antitubercular</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

